TM6SF2 rs58542926 and PNPLA3 rs738409 were both associated with reduced serum triglyceride concentrations and a lower risk of cardiovascular disease,40, 41, 52 and there was probably a synergistic interaction. Here, TM6SF2 is linked to cardiovascular disorder.